Dalton Pharma Services, headquartered in Toronto, Canada, is a prominent player in the pharmaceutical and healthcare industry. While their website doesn't explicitly state "MedTech" as a primary descriptor, their services heavily overlap and support the development and manufacturing of medical technologies. Their core function lies in providing comprehensive contract development and manufacturing organization (CDMO) services. This means they assist pharmaceutical and biotechnology companies with various aspects of drug development, from early-stage research and development to full-scale commercial manufacturing.
Key Services:
Dalton Pharma Services offers a wide range of services catering to the needs of the pharmaceutical and biotechnology sectors. These include, but are not limited to:
Formulation Development: This encompasses the development of stable and effective drug formulations, adapting to various delivery methods (e.g., oral, injectable, topical). Their expertise likely extends to innovative delivery systems relevant to MedTech applications.
Analytical Testing: Rigorous quality control and testing services ensure the safety, purity, and efficacy of pharmaceutical products. This is crucial in the MedTech sector for guaranteeing the reliability of medical devices and implants.
Process Development: Dalton Pharma Services optimizes manufacturing processes for efficiency and scalability, a critical aspect for successfully bringing medical technologies to market.
Manufacturing: They offer both small-scale and large-scale manufacturing capabilities, enabling the production of drug products across various stages of development, from clinical trials to commercial launch. This supports the production of components or even complete medical devices in collaboration with partners.
Packaging and Labeling: They handle the final stages of product preparation, ensuring compliance with regulations and market requirements. This applies equally to pharmaceutical products and some types of MedTech devices.
Regulatory Affairs: Navigating the complex regulatory landscape of drug and medical device development requires expert knowledge. Dalton's services likely encompass assistance with submissions to regulatory bodies like Health Canada.
Target Market:
Dalton Pharma Services primarily serves pharmaceutical and biotechnology companies of various sizes, from small startups to large multinational corporations. Their comprehensive services support the entire lifecycle of drug and potentially related medical technology development and production.
Overall, while not explicitly self-identified as a "MedTech" company, Dalton Pharma Services' core competencies directly support the development and manufacturing of medical technologies through their comprehensive CDMO services. Their capabilities in formulation development, analytical testing, process optimization, and manufacturing are highly relevant to the MedTech sector's needs.
Please note: This information is generated by AI. For legal use, verify with company sources.
